Infection fatality rate of COVID-19 in community-dwelling elderly populations
C Axfors, JPA Ioannidis - European Journal of Epidemiology, 2022 - Springer
This mixed design synthesis aimed to estimate the infection fatality rate (IFR) of Coronavirus
Disease 2019 (COVID-19) in community-dwelling elderly populations and other age groups …
Disease 2019 (COVID-19) in community-dwelling elderly populations and other age groups …
COVID‐19 and plasma cells: Is there long‐lived protection?
DC Nguyen, PA Lamothe, MC Woodruff… - Immunological …, 2022 - Wiley Online Library
Summary Infection with SARS‐CoV‐2, the etiology of the ongoing COVID‐19 pandemic, has
resulted in over 450 million cases with more than 6 million deaths worldwide, causing global …
resulted in over 450 million cases with more than 6 million deaths worldwide, causing global …
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from
therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2
T Hertz, S Levy, D Ostrovsky, H Oppenheimer… - Nature …, 2023 - nature.com
Vaccination, especially with multiple doses, provides substantial population-level protection
against COVID-19, but emerging variants of concern (VOC) and waning immunity represent …
against COVID-19, but emerging variants of concern (VOC) and waning immunity represent …
Sub-optimal neutralisation of omicron (B. 1.1. 529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6 …
GR Medigeshi, G Batra, DR Murugesan… - …, 2022 - thelancet.com
Background Rapid spread of the omicron SARS-CoV-2 variant despite extensive
vaccination suggests immune escape. The neutralising ability of different vaccines alone or …
vaccination suggests immune escape. The neutralising ability of different vaccines alone or …
Defending against SARS-CoV-2: The T cell perspective
P Almendro-Vázquez, R Laguna-Goya… - Frontiers in …, 2023 - frontiersin.org
SARS-CoV-2-specific T cell response has been proven essential for viral clearance, COVID-
19 outcome and long-term memory. Impaired early T cell-driven immunity leads to a severe …
19 outcome and long-term memory. Impaired early T cell-driven immunity leads to a severe …
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
M Krutikov, O Stirrup, H Nacer-Laidi, B Azmi… - The Lancet Healthy …, 2022 - thelancet.com
Summary Background The SARS-CoV-2 omicron variant (B. 1.1. 529) is highly
transmissible, but disease severity appears to be reduced compared with previous variants …
transmissible, but disease severity appears to be reduced compared with previous variants …
[HTML][HTML] Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community …
AMD Navaratnam, M Shrotri, V Nguyen… - International Journal of …, 2022 - Elsevier
Objectives Seroprevalence studies can provide a measure of SARS-CoV-2 cumulative
incidence, but a better understanding of spike and nucleocapsid (anti-N) antibody dynamics …
incidence, but a better understanding of spike and nucleocapsid (anti-N) antibody dynamics …
Decline of humoral and cellular immune responses against SARS-CoV-2 6 months after full BNT162b2 vaccination in hospital healthcare workers
B Bonnet, H Chabrolles, C Archimbaud… - Frontiers in …, 2022 - frontiersin.org
Clinical trials and real-world evidence on COVID-19 vaccines have shown their
effectiveness against severe disease and death but the durability of protection remains …
effectiveness against severe disease and death but the durability of protection remains …
Detecting waning serological response with commercial immunoassays: 18-month longitudinal follow-up of anti-SARS-CoV-2 nucleocapsid antibodies
Y Nakagama, Y Komase, N Kaku, Y Nitahara… - Microbiology …, 2022 - Am Soc Microbiol
Past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is an
important determinant of protection from reinfection and of postvaccine immune responses …
important determinant of protection from reinfection and of postvaccine immune responses …